Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10704651 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL8403752 | 0.96 | LMNA (0.42) | LMNATHRBCA2 | |
| SCHEMBL4020407 | 0.96 | LMNA (0.42) | LMNATHRBCA2 | |
| SCHEMBL815129 | 0.92 | LMNA (0.37) | LMNATHRB | |
| SCHEMBL7574573 | 0.90 | LMNA (0.38) | LMNATHRB | |
| SCHEMBL2553767 | 0.89 | LMNA (0.42) | LMNATHRBCA2 | |
| SCHEMBL534458 | 0.89 | LMNA (0.42) | LMNATHRBCA2 | |
| SCHEMBL4889172 | 0.89 | LMNA (0.42) | LMNATHRBCA2 | |
| SCHEMBL3230572 | 0.89 | LMNA (0.42) | LMNATHRBCA2 | |
| SCHEMBL10341441 | 0.89 | LMNA (0.42) | LMNATHRBCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012012804-A3 | DEVICES FOR SECURING A JUNIOR GOLF BAG TO A GOLF CART AND METHODS OF USE THEREOF | MIZE FREDY (US) | 2012-05-10 | — | — | WO | disclosed |
| EP-2173703-B1 | FLUOROALKYL SURFACTANTS | DU PONT (US) | 2011-11-30 | — | — | EP | disclosed |
| EP-2173703-A1 | FLUOROALKYL SURFACTANTS | E. I. du Pont de Nemours and Company (US) | 2010-04-14 | — | — | EP | disclosed |
| US-7638650-B2 | Fluoroalkyl surfactants | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-12-29 | — | — | US | disclosed |
| WO-2009020910-A1 | FLUOROALKYL SURFACTANTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-02-12 | — | — | WO | disclosed |
| US-20090043130-A1 | Fluoroalkyl surfactants | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090043130-A1 | Fluoroalkyl surfactants | CBR1, CBR3, NHERF1 | LMNA 1392/4885THRB 3050/4885CA2 2001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.